Sofia Spampinato, Kari Tanderup, Jacob C Lindegaard, Maximilian P Schmid, Alina Sturdza, Barbara Segedin, Ina M Jürgenliemk-Schulz, Astrid De Leeuw, Kjersti Bruheim, Umesh Mahantshetty, Cyrus Chargari, Bhavana Rai, Rachel Cooper, Elzbieta van der Steen-Banasik, Marit Sundset, Ericka Wiebe, Elena Villafranca, Erik Van Limbergen, Bradley R Pieters, Li Tee Tan, Ludy C H W Lutgens, Peter Hoskin, Stéphanie Smet, Richard Pötter, Remi Nout, Supriya Chopra, Kathrin Kirchheiner
PURPOSE: To quantify the association of persistent morbidity with different aspects of quality of life (QOL) in locally advanced cervical cancer (LACC) survivors. MATERIAL AND METHODS: Longitudinal outcome from the EMBRACE-I study was evaluated. Patient-reported symptoms and QOL were prospectively scored (EORTC-C30/CX24) at baseline and regular follow-ups. Physician-assessed symptoms were also reported (CTCAEv.3). Persistent symptoms were defined if present in at least half of the follow-ups...
April 2023: Radiotherapy and Oncology